Trademark: 79074723
Word
CLB-TRANSFECTION
Status
Dead
Status Code
404
Status Date
Wednesday, August 28, 2019
Serial Number
79074723
Registration Number
3790467
Registration Date
Tuesday, May 18, 2010
Mark Type
4000
Filing Date
Friday, August 28, 2009
Published for Opposition
Tuesday, March 2, 2010
Cancellation Date
Wednesday, August 28, 2019

Trademark Owner History
Lonza Cologne GmbH - Original Registrant
Lonza Cologne AG - Owner At Publication

Classifications
1 Chemical and biochemical preparations used in industry and science for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins; buffer and standard solutions for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins, for scientific and research use; chemical preparations for scientific purposes in the nature of laboratory chemicals for cell culture, namely, aqueous solutions containing nutrients for cultivating living cells; biological agents, namely, buffer and standard solutions containing living cells, proteins, peptides and/or nucleic acid molecules for laboratory use other than for medical and veterinary purposes; diagnostic preparations other than for medical and veterinary purposes; biological reagents for laboratories, namely, peptides, proteins, nucleic acids and complexes made of peptides, proteins and/or nucleic acids, for scientific and research use, namely, for detecting gene expression and localizing proteins as well as for integrating foreign nucleic acids into the genome of living cells and transient production of proteins for laboratory use; chemicals for use in science to transfer foreign genetic material into another cell, namely, nucleic acid molecules in the nature of expression and control vectors for laboratory use; biochemical reagents for non-medical purposes commonly known as transfection reagents for transient production of proteins for laboratory use
5 Pharmaceutical preparations for the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; diagnostic preparations for medical and veterinary use; living cells for medical or clinical use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; cultures of microorganisms, namely, bacterial and viral preparations for medical or clinical use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; proteins, peptides, nucleic acid sequences and biochemical reagents of these molecules for medical and veterinary use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer
9 Scientific apparatus and instruments, namely, electrical equipment in the nature of electrical field generators and capacitor impulse generators for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins; apparatus and instruments for electroporation, namely, electroporators and their peripheral equipment; apparatus and instruments for conducting, switching, converting, storing, controlling and monitoring of electricity, namely, electrical capacitors, electrical conductors and contacts, power semiconductors, transistors, relays, transformers, and electric parameter monitor modules; laboratory equipment and supplies, namely, devices, containers and reaction vessels for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins; test tubes; electrodes made of metal and conductive polymers; cuvettes, namely, test tubes having electrodes made of metal and conductive polymers for biochemical purposes; multi-well plates having electrodes made of metal and conductive polymers for biochemical purposes; data processors and computers; computer peripherals; computer programs and software recorded on data media designed for use in controlling of scientific apparatus and instruments for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins

Trademark Events
Mar 27, 2020
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Mar 27, 2020
Death Of International Registration
Sep 29, 2017
Total Invalidation Processed By The Ib
Aug 28, 2017
Total Invalidation Of Reg Ext Protection Sent To Ib
Aug 28, 2017
Invalidation Processed
Aug 23, 2017
Total Invalidation Of Reg Ext Protection Created
Dec 23, 2016
Cancelled Section 71
May 18, 2015
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jan 9, 2013
Correction From The Ib Examined, No Action Is Needed
Dec 29, 2012
Correction Transaction Received From Ib
Aug 3, 2012
New Representative At Ib Received
Nov 11, 2011
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 11, 2011
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 5, 2011
Change Of Name/Address Rec'd From Ib
May 18, 2010
Registered-Principal Register
Mar 2, 2010
Published For Opposition
Feb 10, 2010
Notice Of Publication
Jan 28, 2010
Law Office Publication Review Completed
Jan 28, 2010
Assigned To Lie
Jan 5, 2010
Approved For Pub - Principal Register
Dec 3, 2009
Assigned To Examiner
Dec 2, 2009
Application Filing Receipt Mailed
Nov 28, 2009
New Application Office Supplied Data Entered In Tram
Nov 27, 2009
Limitation Of Goods/Services From Ib Entered
Nov 26, 2009
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24